Key Highlights

  • KP Tissue Inc. carries an indicated Dividend Yield of 7.19%, based on a quarterly dividend of C$0.21 per share, or C$0.84 per year.
  • Shares were indicated at C$11.69, a decline of 0.55%, below the C$13.00 level seen in mid-July.
  • The dividend was raised from C$0.18 to C$0.21 in May 2026 because dividends are now designated as non-eligible for Canadian tax purposes.
  • Kruger Products reported second-quarter adjusted EBITDA up 25% to C$90.6 million, with Revenue of C$550.9 million.
  • KP Tissue holds only a 12.0% interest in Kruger Products, so its dividend depends on distributions from that operating company.

Introduction

KP Tissue Inc. (TSX:KPT) is a Holding Company whose only Business is a 12.0% Equity interest in Kruger Products Inc., Canada's leading maker of tissue products including the White Cloud Brand and premium private label.

KP Tissue Inc. shares were indicated at C$11.69, a decline of 0.55%, and the indicated dividend yield of 7.19% reflects the C$0.84 annualized payout against that price.

The company pays dividends that match those declared by Kruger Products, so the sustainability question is really about Kruger Products' cash flow.

The recent increase is tied to tax designation rather than to a change in underlying distributable cash.

Company Overview

Kruger Products second-quarter revenue rose 2.8% to C$550.9 million, with growth led by the U.S. business, where sales increased 9.5%.

Adjusted EBITDA grew 25% to C$90.6 million on higher U.S. volumes, lower pulp prices and improved performance at the Memphis facility, while Canada remained soft.

Net income was C$22.1 million, unchanged from a year earlier, and total Liquidity was C$422.6 million at the end of June.

CEO Dino Bianco leads both KP Tissue and Kruger Products, and management expects third-quarter adjusted EBITDA to be in the range of the second quarter.

Dividend Profile

KP Tissue declared a quarterly dividend of C$0.21 per share payable on 15 July 2026, up from the historical C$0.18.

The increase reflects the change in tax designation of the dividend from eligible to non-eligible, with other Kruger Products shareholders waiving part of their dividend.

The company expects the non-eligible designation to continue for the October payment while it works toward restoring eligible status.

The dividend is declared in connection with a matching dividend by Kruger Products.

Investors in taxable accounts should note that non-eligible dividends do not receive the enhanced dividend tax credit.

Dividend Sustainability Analysis

KP Tissue passes through the dividends it receives, so sustainability depends on Kruger Products' earnings, Leverage and cash needs.

Payout Ratio and Earnings Coverage

Kruger Products' Net Income of C$22.1 million and adjusted EBITDA of C$90.6 million indicate healthy earnings, but the 12% stake means KP Tissue's share is modest.

Because KP Tissue's business is limited to holding the interest, its dividend should not exceed distributions received.

The tax-driven increase does not change the amount of pre-tax cash available.

Adjusted Cash Flow Coverage

Lower pulp prices improved margins in the quarter, though pulp prices rose sequentially.

The Memphis Facility in the United States is contributing more, and U.S. sales growth of 9.5% is a positive.

Canadian Demand remains soft, partly offset by operational efficiencies in the Away-From-Home business.

Balance Sheet and Leverage

Kruger Products carries meaningful Debt after years of capital investment, though leverage has improved.

Total liquidity of C$422.6 million includes cash and undrawn Credit facilities.

Investors should watch interest costs and capital spending at the operating company.

Liquidity

Liquidity at Kruger Products is ample relative to near-term needs.

KP Tissue itself has limited Assets beyond its equity investment.

Revenue Stability and Profit Trends

Revenue growth of 2.8% was driven by the U.S. and operational efficiency, while Canadian volumes were softer.

The company expects third-quarter adjusted EBITDA to be in the range of the second quarter.

Interest Rate and Commodity Exposure

Pulp and energy prices influence margins, and Kruger Products has seen lower pulp costs.

Currency affects U.S. earnings in Canadian dollars.

Counterparty Concentration

Major retailers are large customers, and private label business concentrates exposure on a few chains.

KP Tissue's counterparties are essentially the controlling shareholders of Kruger Products.

Management Commentary

Management says the company maintained strong momentum despite economic uncertainty.

It is working toward restoring the eligible designation of dividends as soon as possible.

Sector-Specific Dividend Risks

Tissue Manufacturing is exposed to pulp price swings, retailer bargaining power and capacity additions.

Tariffs and trade policy can affect cross-border sales.

Red Flags

  • KP Tissue holds only a 12.0% minority interest.
  • Dividends are now non-eligible, which affects after-tax value for some investors.
  • Canadian demand is soft.
  • Pulp price swings can compress margins.
  • Net income was flat year over year.

Bull Case

  • Strong EBITDA growth and improving U.S. operations support continued distributions.
  • A return to eligible dividend status could improve after-tax appeal.

Bear Case

  • Higher pulp prices or weaker volumes could reduce Kruger Products' cash flow.
  • Non-eligible designation could persist longer than expected.

Latest News and Developments

  • On 13 August 2026, KP Tissue reported second-quarter results with Kruger Products adjusted EBITDA up 25% to C$90.6 million.
  • In May 2026, KP Tissue raised its quarterly dividend to C$0.21 due to a change in tax designation.
  • The company said the non-eligible designation is expected to continue for the October 2026 dividend.

Dividend Sustainability Rating

Rating: Moderately Sustainable

The dividend looks supported by strong Kruger Products earnings, with the tax-driven increase reflecting designation rather than extra cash.

The assessment draws on a 25% rise in adjusted EBITDA, solid liquidity and a stable payout arrangement.

The rating is moderate because KP Tissue is a minority holder and margins depend on pulp prices.

Investor Takeaway

KP Tissue offers a high indicated yield from a stable tissue manufacturer.

Tax designation matters for after-tax returns.

Watch Kruger Products' EBITDA, pulp prices and any change in dividend designation.